Open AccessBaroreflex activation therapy reduces frequency and duration of hypertension-related hospitalizations in patients with resistant hypertension
Author(s) -
Marcel Halbach,
David Grothaus,
Fabian Hoffmann,
Navid Madershahian,
Kathrin Kuhr,
Hannes Reuter
Publication year - 2020
Publication title -
clinical autonomic research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.245
H-Index - 58
eISSN - 1619-1560
pISSN - 0959-9851
DOI - 10.1007/s10286-020-00670-9
Subject(s) - medicine , blood pressure , baroreflex , ambulatory blood pressure , medical record , diabetes mellitus , anesthesia , cardiology , emergency medicine , heart rate , endocrinology
Baroreflex activation therapy (BAT) has been shown to lower blood pressure in patients with resistant hypertension. The purpose of this study was to analyze whether this translates into a reduction of more relevant clinical endpoints.